Acceptance of the New Drug Application is based on findings from a phase 2b portion of the open-label REZILIENT1 clinical trial.
QINGDAO CITY, SHANDONG PROVINCE, CHINA, April 3, 2026 /EINPresswire.com/ — The global market for metal labels and decorative stickers has expanded steadily in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results